Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SZC in Hemodialysis Patients With Hyperkalemia (China Phase 3)
CTR20200910Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in hyperkalemia, sponsored by AstraZeneca. Started Sep 2020; status: completed.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on CTR20200910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200910.